Molecular Assemblies was founded in early 2013 to develop a new enzymatic method of DNA synthesis inspired by the way nature makes DNA. Today's method of chemical DNA synthesis is incapable of producing high quality, gene-length DNA that is cost effective and scalable. It also relies on harsh chemicals that both damage the DNA and produce high volumes of toxic waste. Molecular Assemblies' enzymatic approach will produce long, high quality, sequence-specific DNA, reliably, affordably and sustainably, and overcome the limitations of traditional chemical DNA synthesis. The $2.3 million consists of cash and conversion of promissory notes with funds being utilized to advance its research and development efforts.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/12/16 | $2,300,000 | Seed |
Agilent Technologies Alexandria Real Estate Equities Cavendish Impact Capital Fund Eleven Two Capital Keshif Ventures Newport Holdings | undisclosed |
| 04/15/21 | $24,000,000 | Series A |
Agilent Technologies Alexandria Venture Investments Argonautic Ventures Codexis iSelect Fund LYFE Capital | undisclosed |
